Year: 2013
Type: dissertation
Abstract: The human immunodeficiency virus (HIV-1), which is the causative agent of the acquired immunodeficiency syndrome (AIDS), enters its cells by utilizing its envelope (spike) multiprotein complex. The spike is trimer composed of gp120 and gp41. For fusion of HIV-1 with the host cell membrane, it interacts with its receptor (CD4) and a coreceptor (CCR5 or CXCR4). These interactions are initiated by gp120 and result in conformational changes inside of the spike that enable gp41 to mediate fusion of the viral and host cell membranes. Despite intensive research, AIDS can not be cured and causes more than 1.5 million deaths annually. Until today, a potent HIV-1 vaccine is still elusive. This is mainly due to intensive immune escape mechanisms and shielding of potently neutralizing epitopes on the virus, which is challenging for developing vaccines based on whole proteins or protein complexes (like the spike). To overcome this problem, peptides as binding site mimetics are suitable tools. Displaying only the CD4- or coreceptor-binding site of gp120 through peptides could therefore not only improve our understanding of the molecular details on virus - host cell interaction, but also display potent vaccines in the battle against HIV-1. In this study, the molecular details of the interaction of one CD4-binding site mimetic (CD4bs-M) as well as coreceptor-binding site mimetics (V3-loop peptides) were analysed. The previously published discontinuous binding site mimetic CD4bs-M had been shown to compete with gp120 for binding to CD4. Interestingly, it could be shown in the current study that CD4bs-M is able to bind to gp120 in direct ELISA. Furthermore, it strongly enhanced HIV-1 infection of susceptible target cells. This effect could be linked to the β20/β21-fragment of CD4bs-M, which is part of the bridging sheet of gp120. Using different substitution variants, it could be shown that a defined side-chain orientation, peptide backbone and spatial orientation of this fragment is necessary for the interaction with gp120 as well as the infection enhancement. Moreover, CD4bs-M was able to trigger infection of CD4-negative HeLa cells with HIV-1, leading to the hypothesis that the β20/β21-fragment of CD4bs-M adopts a defined conformation while interacting with gp120, which in turn facilitates interaction of gp120 with its coreceptors. In HIV-1 infection, the primary humoral immune response is preferentially directed against the V3-loop of gp120. Unfortunately, the generated antibodies have, in most cases, only a limited neutralizing capacity and can, therefore, be easily bypassed by HIV-1 through immune escape mechanisms like single nucleotide polymorphisms that cause an amino acid substitution or shielding of the corresponding epitopes. Nevertheless, some broadly neutralizing anti-V3-loop antibodies have been isolated from HIV-1 longterm non-progressors. Besides HIV-1 strains with amino acid substitutions in their V3-loop sequence, HIV-1 strains with amino acid insertions in the V3 loop are known. For example the HIV-1LAI strain, which HIV-1IIIB, HIV-1HxBc2 and HIV-1NL4.3 originate from, has a dipeptide insertion (QR insert) in the V3-loop tip. In this study, it could be shown, using V3-loop peptides containing insertions and deletions of this particular dipeptide, that most of the broadly neutralizing anti-V3-loop antibodies are strictly dependent on V3-loops that do not contain this insert. Immunisation of mice with two V3-loop peptides of strainHxBc2 (one with and one without QR-insert) resulted in antibody responses that were strictly dependend on the QR-insert. Using substitution analogs of the QR-insert in V3-loop peptides, it could be demonstrated that substitution of arginine to isoleucine renders the V3-loop capable at binding to the QR-dependent anti-V3-loop antibodies. V3-loop peptides with QI-Insertion could possibly serve as potent vaccines to induce antibodies that could recognize V3-loops with as well as without QR-insert and could thus be used to avoid immune escape of HIV-1 through amino acid insertions in the V3-loop tip. As the main determinant of coreceptor tropism, the V3-loop of gp120 had been intensively studied. However, due to the high complexity of the spike, as well as the barrier to study the membrane-bound coreceptors in in vitro assay systems like ELISA, the interaction of the V3-loop with the corresponding coreceptor (CCR5 or CXCR4) is not well understood. To overcome this problem, a CXCR4 coreceptor mimetic peptide, called CX4-M1, was recently developed in our group that mimics the three extracellular loops of the coreceptor. This mimetic is able to selectively bind gp120 of CXCR4-using HIV-1, whereas gp120 of CCR5-using HIV-1 is not recognized. Furthermore, CX4-M1 is able to inhibit HIV-1 infection of CXCR4-using HIV-1. In this study, it could be shown that CX4-M1 not only discriminates between gp120 of different tropism, but also selectively recognizes V3-loop peptides of CXCR4-using HIV-1. In addition, it could be shown in infection assays that a V3-loop peptide of CXCR4-using HIV-1 is able to counteract infection inhibition through CX4-M1. Using substitution analogs of the V3-loop peptides as well as of the second extracellular loop of CX4-M1, the binding sites of both peptides for each other could be dissected on the level of individual amino acids. Beyond the exploration of the molecular details of this interaction, these results clearly demonstrate the feasibility of mimicking protein-protein interactions through peptide-peptide interactions. Peptides are therefore valuable tools to dissect the molecular mechanism of HIV-1 entry into cells and have the potential to serve as new drugs and vaccines.
Author: Groß, Andrea
Institution: Friedrich-Alexander-Universität Erlangen-Nürnberg
Language: German
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7048758077
